CD28 and neoplasm: The T-cell receptor recognizes the binding between the antigen peptide-MHC complex on the surface of APC, the B7 molecule on the surface of APC and the dimer molecule CD28 on the surface of T cells, and the dual signal starts to activate T cells (the dual signal system regulation can review the immune response and tumor immunotherapy) (Step 3).